2024
U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention
Rosenblum H, Gargano J, Cleveland A, Dahl R, Park I, Whitney E, Castilho J, Sackey E, Niccolai L, Brackney M, Debess E, Ehlers S, Bennett N, Kurtz R, Unger E, Markowitz L. U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention. Journal Of Women's Health 2024, 33: 594-603. PMID: 38608239, DOI: 10.1089/jwh.2023.0462.Peer-Reviewed Original ResearchInvasive cervical cancerEvaluate characteristics of womenPopulation-based descriptive studyInvasive cervical cancer diagnosisCervical cancer screeningReduce cervical cancer ratesPopulation-based surveillance sitesCervical cancer ratesIdentified potential barriersNon-white womenAdvent of screeningPotential barriersCharacteristics of womenIncident invasive cervical cancerCancer screeningPreventive careCancer ratesCervical cancerMental illnessSubstance use disordersChi-square testDescriptive frequenciesDescriptive studyMultiple barriersSurveillance sites
2023
Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15AgeA review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang W, Kothari S, Khoury H, Niccolai L, Garland S, Sundström K, de Pouvourville G, Bonanni P, Chen Y, Franco E. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review Of Vaccines 2023, 22: 161-179. PMID: 36576068, DOI: 10.1080/14760584.2023.2162505.Peer-Reviewed Original ResearchConceptsHigh-income countriesHPV vaccinationCervical cancer prevention policyCharacteristics of HPVHuman papillomavirus vaccinationCervical screening programmeEarly detection measuresCancer prevention policiesWorld Health OrganizationPapillomavirus vaccinationCervical cancerVaccination coverageDisease outcomeScreening programElimination effortsGlobal eliminationPrevention programsTreatment programData SystemVaccinationHealth OrganizationHPVTargeted reviewPrevention policiesUnited States
2019
962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016
Gargano J, Lewis R, Hunt H, McClung N, Bennett N, Griffin M, Niccolai L, Park I, Powell M, Brackney M, Scahill M, Pemmaraju M, Fink D, Ehlers S, Cleveland A, Unger E, Markowitz L. 962. Trends in Cervical Pre-cancers by Race and Ethnicity During the Human Papillomavirus Vaccine Era, HPV Vaccine Impact Monitoring Project (HPV-IMPACT), United States, 2008–2016. Open Forum Infectious Diseases 2019, 6: s29-s29. PMCID: PMC6809029, DOI: 10.1093/ofid/ofz359.064.Peer-Reviewed Original ResearchAverage annual percentage changeCervical intraepithelial neoplasiaRace/ethnicityVaccine eraYear oldsNH blacksNH whitesHuman papillomavirus vaccine introductionActive population-based surveillanceHPV vaccine eraPopulation-based surveillanceConfidence intervalsAnnual percentage changeSignificant declineScreened womenVaccine impactRace/ethnicity dataCervical cancerIntraepithelial neoplasiaVaccine introductionCIN2Hispanic womenJoinpoint softwareSitu casesAge groups